Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mukesh C. Gohel & Stavan A. Nagori. (2009) Fabrication and design of transdermal fluconazole spray. Pharmaceutical Development and Technology 14:2, pages 208-215.
Read now
Read now
Eva R. Trösken, Karoline Scholz, Roman W. Lutz, Wolfgang Völkel, Jürg A. Zarn & Werner K. Lutz. (2004) Comparative Assessment of the Inhibition of Recombinant Human CYP19 (Aromatase) by Azoles Used in Agriculture and as Drugs for Humans. Endocrine Research 30:3, pages 387-394.
Read now
Read now
Laura Kragie. (2002) AROMATASE IN PRIMATE PREGNANCY: A REVIEW. Endocrine Research 28:3, pages 121-128.
Read now
Read now
Articles from other publishers (28)
Feng-Jiao Peng, Paul Palazzi, Sakina Mezzache, Emilie Adelin, Nasrine Bourokba, Philippe Bastien & Brice M. R. Appenzeller. (2023) Association between Environmental Exposure to Multiclass Organic Pollutants and Sex Steroid Hormone Levels in Women of Reproductive Age. Environmental Science & Technology 57:48, pages 19383-19394.
Crossref
Crossref
Christa E. Flück, Maria Natalia Rojas Velazquez & Amit V. Pandey. 2023. Genetic Steroid Disorders. Genetic Steroid Disorders
239
264
.
Monica Kam Draskau & Terje Svingen. (2022) Azole Fungicides and Their Endocrine Disrupting Properties: Perspectives on Sex Hormone-Dependent Reproductive Development. Frontiers in Toxicology 4.
Crossref
Crossref
Marcella Tapias Passoni, Daniele Cristine Krebs Ribeiro, Samara Christina França de Almeida, Bruna Furtado da Costa, Nicole Grechi, Sara Emilia Lima Tolouei, Tatiana Zauer Curi, Mônica Degraf Cavallin, Renata Marino Romano, Marco Aurélio Romano, Katherinne Maria Spercoski, Ariany Carvalho dos Santos, Roosevelt Isaias Carvalho Souza, Paulo Roberto Dalsenter & Anderson Joel Martino-Andrade. (2022) The Analgesic Dipyrone Affects Pregnancy Outcomes and Endocrine-Sensitive Endpoints in Female and Male Offspring Rats. Toxicological Sciences 187:1, pages 80-92.
Crossref
Crossref
Monica Kam Draskau, Anna Kjerstine Rosenmai, Martin Scholze, Mikael Pedersen, Julie Boberg, Sofie Christiansen & Terje Svingen. (2021) Human-relevant concentrations of the antifungal drug clotrimazole disrupt maternal and fetal steroid hormone profiles in rats. Toxicology and Applied Pharmacology 422, pages 115554.
Crossref
Crossref
Nicolas Lebouvier, Fabrice Pagniez, Young Min Na, Da Shi, Patricia Pinson, Mathieu Marchivie, Jean Guillon, Tarek Hakki, Rita Bernhardt, Sook Wah Yee, Claire Simons, Marie-Pierre Lézé, Rolf W. Hartmann, Angélique Mularoni, Guillaume Le Baut, Isabelle Krimm, Ruben Abagyan, Patrice Le Pape & Marc Le Borgne. (2020) Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Pharmaceuticals 13:8, pages 186.
Crossref
Crossref
Philipp Conradi. (2020) Caution Is Indicated. Deutsches Ärzteblatt international.
Crossref
Crossref
Cecilie Hurup Munkboel, Tobias Bangsgaard Rasmussen, Camilla Elgaard, Maja-Luna Kingo Olesen, Andreas Christopher Kretschmann & Bjarne Styrishave. (2019) The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax. Toxicology 425, pages 152247.
Crossref
Crossref
E P Garvey, A D Sharp, P A Warn, C M Yates & R J Schotzinger. (2018) The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis. Journal of Antimicrobial Chemotherapy 73:10, pages 2815-2822.
Crossref
Crossref
M.J. Yapura, E.M. Zwiefelhofer, R.A. Pierson & G.P. Adams. (2018) Aromatase inhibitors: A new approach for controlling ovarian function in cattle. Theriogenology 112, pages 18-25.
Crossref
Crossref
V.M. Patel, R.A. Schwartz & W.C. Lambert. (2017) Topical antiviral and antifungal medications in pregnancy: a review of safety profiles. Journal of the European Academy of Dermatology and Venereology 31:9, pages 1440-1446.
Crossref
Crossref
Christa E. Flück & Amit V. Pandey. (2017) Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase. The Journal of Steroid Biochemistry and Molecular Biology 165, pages 64-70.
Crossref
Crossref
J. Yapura, I. Badea, G. Zamberlam, C. Price, R. Mapletoft, R. Pierson, J. Singh & G.P. Adams. (2015) Formulation and testing of a non-steroidal aromatase inhibitor intravaginal device for the control of ovarian function in cattle. Animal Reproduction Science 156, pages 91-102.
Crossref
Crossref
Gwendolyn Louis & Tammy Stoker. 2015. Mammalian Toxicology. Mammalian Toxicology
289
308
.
A. G. S. Warrilow, C. M. Hull, J. E. Parker, E. P. Garvey, W. J. Hoekstra, W. R. Moore, R. J. Schotzinger, D. E. Kelly & S. L. Kelly. (2014) The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme. Antimicrobial Agents and Chemotherapy 58:12, pages 7121-7127.
Crossref
Crossref
L. A. Kaluzhskiy, O. V. Gnedenko, A. A. Gilep, N. V. Strushkevich, T. V. Shkel, M. A. Chernovetsky, A. S. Ivanov, A. V. Lisitsa, A. S. Usanov, V. A. Stonik & A. I. Archakov. (2014) Screening of human cytochrome P450(51) (CYP51A1) inhibitors: Structural lanosterol analogues of plant and animal origin. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 8:4, pages 349-360.
Crossref
Crossref
L.A. Kaluzhskiy, O.V. Gnedenko, A.A. Gilep, N.V. Strushkevich, T.V. Shkel, M.A. Chernovetsky, A.S. Ivanov, A.V. Lisitsa, S.A. Usanov, V.A. Stonik & A.I. Archakov. (2014) The screening of the inhibitors of the human cytochrome P450(51) (CYP51A1): the plant and animal structural lanosterol's analogs. Biomeditsinskaya Khimiya 60:5, pages 528-537.
Crossref
Crossref
Jenny E. Murase, Misha M. Heller & Daniel C. Butler. (2014) Safety of dermatologic medications in pregnancy and lactation. Journal of the American Academy of Dermatology 70:3, pages 401.e1-401.e14.
Crossref
Crossref
Carly A. Elston & Dirk M. Elston. (2013) Treatment of common skin infections and infestations during pregnancy. Dermatologic Therapy 26:4, pages 312-320.
Crossref
Crossref
Amit V. Pandey & Christa E. Flück. (2013) NADPH P450 oxidoreductase: Structure, function, and pathology of diseases. Pharmacology & Therapeutics 138:2, pages 229-254.
Crossref
Crossref
Gurbet Celik, Aslı Semiz, Serdar Karakurt, Sevki Arslan, Orhan Adali & Alaattin Sen. (2013) A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Christa E. Flück & Amit V. Pandey. 2013. Genetic Steroid Disorders. Genetic Steroid Disorders
125
143
.
Christa E. Flück, Primus E. Mullis & Amit V. Pandey. (2010) Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. Biochemical and Biophysical Research Communications 401:1, pages 149-153.
Crossref
Crossref
Catherine Nicolo, Christa E. Flück, Primus E. Mullis & Amit V. Pandey. (2010) Restoration of mutant cytochrome P450 reductase activity by external flavin. Molecular and Cellular Endocrinology 321:2, pages 245-252.
Crossref
Crossref
Nehama Linder, Mandola Amarilla, Adriana Hernandez, Tsippy Tamiri, Lea Sirota, Gil Klinger, Itzhak Levy & Paul Merlob. (2009) Association of high‐dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn. Birth Defects Research Part A: Clinical and Molecular Teratology 88:3, pages 201-204.
Crossref
Crossref
N.W. Jacobsen, B. Halling-Sørensen & F.K. Birkved. (2008) Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. Toxicology in Vitro 22:1, pages 146-153.
Crossref
Crossref
Nga Ta & Thomas Walle. (2007) Aromatase inhibition by bioavailable methylated flavones. The Journal of Steroid Biochemistry and Molecular Biology 107:1-2, pages 127-129.
Crossref
Crossref
Eva R. Trösken, Kathrin Fischer, Wolfgang Völkel & Werner K. Lutz. (2006) Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC–MS/MS method for the analysis of estradiol product formation. Toxicology 219:1-3, pages 33-40.
Crossref
Crossref